INDUSTRY LAUNCHES $1B SUPERBUG FUND — Pharmaceutical companies on Thursday launched a fund backed by a pledge of $1 billion in industry cash to produce two to four new antibiotics in the next 10 years, POLITICO’s Ashleigh Furlong reports.
The AMR Action Fund aims to invest in smaller biotechs focused on developing new antibiotics; give technical support to these companies; and bring together philanthropic organizations, development banks and governments “to create market conditions that enable sustainable investment in the antibiotic pipeline.”
The companies involved in the fund include GSK, Johnson & Johnson, Roche and Pfizer, along with trade groups such as PhRMA, BIO and the International Federation of Pharmaceutical Manufacturers.
Read the entire Prescription Pulse newsletter here.